In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar

<h3>Background</h3><p dir="ltr">Serological assays targeting antibodies against key viral proteins, including the Spike (S1), Receptor Binding Domain (RBD), and Nucleocapsid, play a critical role in understanding immunity and supporting diagnostic efforts during COVID-19...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Nishant N. Vaikath (2901785) (author)
مؤلفون آخرون:	Maryam Ali Al-Nesf (13040248) (author), Nour Majbour (3528548) (author), Houari B. Abdesselem (14152827) (author), Vijay Gupta (209146) (author), Ilham Bensmail (12204845) (author), Ilham Y. Abdi (14778898) (author), Khalifa Ahmed Elmagarmid (20923799) (author), Shadah Shabani (20923802) (author), Indulekha P. Sudhakaran (9611154) (author), Simona S. Ghanem (12267227) (author), Mohammed Al-Maadheed (12204886) (author), Vidya Mohamed-Ali (12204895) (author), Jonathan M. Blackburn (699590) (author), Julie Decock (44558) (author), Omar M.A. El-Agnaf (18595255) (author)
منشور في:	2025
الموضوعات:	Biological sciences Microbiology Biomedical and clinical sciences Immunology Health sciences Epidemiology Public health COVID-19 SARS-CoV-2 IgM and IgG Neutralization assay Sengenics Urine diagnostics Serological assays
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar

مواد مشابهة